Skip to main content

Advertisement

Log in

The Effect of Ecdystene on the Activity of Matrix Metalloproteinases in Experimental Alloxan Diabetes in Rats

  • Published:
BioNanoScience Aims and scope Submit manuscript

Abstract

The article presents data on the study of the influence of “Ecdystene” on the development of alloxane diabetes, the activity of matrix metalloproteinases, and the content level of their inhibitors. Metalloproteinases are involved in various physiological and pathological processes requiring proliferation and migration of cells and, consequently, restructuring of the extracellular matrix. When applied for treatment during 14 and 21 days, Ecdystene surpasses glucose and Retabolil in terms of hypoglycemic action. In alloxane diabetes, there is a reliable increase in the activity of metalloproteinases, especially on the 14th day of its development. Contrary to comparison preparations, Ecdystene has a more pronounced effect on metalloproteinase activity. Treatment with Ecdystene for 14 and 21 days contributed to an increase in the TIMP-1 content by 2.2 and 1.5 times compared to the untreated group. Glucose and Retabolil increased the content of TIMP-1 on the 7th and 14th days of treatment by 1.26; 0.9 and 1.48; 1.17 times compared to the untreated group. Changes in the activity of MMPs contribute to a decrease in catabolism of the components of the extracellular matrix. To achieve high efficiency in the treatment of diabetes in the clinic, it is recommended to use Ecdystene in combination with other drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Sabirova, R. A., & Tursunov, D. K. (2018). The value of determining the activity of metalloproteinases in the diagnosis and treatment of diabetes mellitus: Methodical recommendations. Tashkent Medial Academy Publishing.

    Google Scholar 

  2. Zimmet, P., Shaw, J., & Alberti, K. G. M. M. (2003). Preventing Type 2 diabetes and the dysmetabolicsyndrome in the real world: A realistic view. Diabetic Medicine, 20, 693–702. https://doi.org/10.1046/j.1464-5491.2003.01052.x

    Article  Google Scholar 

  3. Sabirova, R. A., Tursunov, D. K., Qadirova, D. A., & Yuldasheva, D. Y. (2017). Effect of ecdisten on the condition of the nitrogen oxide system in the development of alloxane diabetes. The European Science Review, 9–10, 49–53.

    Google Scholar 

  4. Tursunov, D. K., Sabirova, R. A., Kasimov, E. R., & Kadirova, M. A. (2016). The role of matrix metalloproteinases in the development of pathological conditions. Bulletin of the Tashkent Medical Academy, 1, 26–28.

    Google Scholar 

  5. Bobkova, I. N., Kozlovskaya, L. V., & Li, O. A. (2008). The role of matrix metalloproteinases in pathogenesis of renal disease. Terapevticheskii Arkhiv, 6, 86–90.

    Google Scholar 

  6. Suarsana, N., Utama, I. H., & Kardena, I. M. (2016). Immunohistochemical expression of insulin and glucagon, superoxide dismutase and catalase activity in pancreas in hyperglycaemia condition. Asian Journal of Biochemistry, 11, 177–185. https://doi.org/10.3923/ajb.2016.177.185

    Article  Google Scholar 

  7. Adiguzel, E., Hou, G., Sabatini, P. J., & Bendeck, M. P. (2013). Type VIII collagen signals via β1 integrin and RhoA to regulate MMP-2 expression and smooth muscle cell migration. Matrix Biology, 32, 332–341. https://doi.org/10.1016/j.matbio.2013.03.004

    Article  Google Scholar 

  8. Woessner, F. J., & Nagase, H. (2011). Matrix metalloproteinases and TIMPs. Oxford University Press.

    Google Scholar 

  9. Brown, D. L., Desai, K. K., Vakili, B. A., Nouneh, C., Lee, H. M., & Golub, L. M. (2004). Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 733–738. https://doi.org/10.1161/01.ATV.0000121571.78696.dc

    Article  Google Scholar 

  10. Cunningham, L. A., Wetzel, M., & Rosenberg, G. A. (2005). Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia, 50, 329–339. https://doi.org/10.1002/glia.20169

    Article  Google Scholar 

  11. Timofeev, N. P. (2004). Studies on ecdysteroids: Use in medicine, Internet resources, sources and biological activity. Biomedical Chemistry, 50, 133–152.

    Google Scholar 

  12. Vasiliev, A. S., Abdrashitova, N. Y., & Udut, V. V. (2015). Ecdysteroids and their biological activity. Plant Resources, 51, 229–259.

    Google Scholar 

  13. Petchi, R. R., Vijaya, C., & Parasuraman, S. (2014). Antidiabetic activity of polyherbal formulation in streptozotocin-nicotinamide induced diabetic Wistar rats. Journal of Traditional and Complementary Medicine, 4, 108–117. https://doi.org/10.4103/2225-4110.126174

    Article  Google Scholar 

  14. Antia, B. S., Okokon, J. E., & Okon, P. A. (2005). Hypoglycemic activity of aqueous leaf extract of Persea americana Mill. Indian Journal of Pharmacology, 37, 325–326. https://doi.org/10.4103/0253-7613.16858

    Article  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

Not applicable.

Corresponding author

Correspondence to Djakhangir Khusanovich Tursunov.

Ethics declarations

Ethics Approval

Not applicable.

Informed Consent

Not applicable.

Consent for Publication

Not applicable.

Conflicts of Interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tursunov, D.K., Sabirova, R.A., Kulmanova, M.U. et al. The Effect of Ecdystene on the Activity of Matrix Metalloproteinases in Experimental Alloxan Diabetes in Rats. BioNanoSci. 11, 923–928 (2021). https://doi.org/10.1007/s12668-021-00903-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12668-021-00903-9

Keywords

Navigation